Related Experiment Video
Updated: Sep 11, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
The Role of Nuclear Phosphoinositides in the p53-MDM2 Nexus
Jeong Hyo Lee1,2, Muhammad Khalil Salah1,2, Xiangqin Chen1
1University of Wisconsin Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.
Abstract:
Recent insights into the p53-MDM2 nexus have advanced deeper understanding of their regulation and potent impact on cancer heterogeneity. The roles of nuclear phosphoinositide (PIPns) in modulating this pathway are emerging as a key mechanism. Here, we dissect the molecular mechanisms by which nuclear PIPns stabilize p53 through the recruitment of small heat shock proteins (sHSPs), activate the nuclear phosphatidylinositol 3-kinase (PI3K)-AKT signaling cascade, and modulate MDM2 function to regulate the p53-MDM2 interaction. We propose potential mechanisms by which nuclear PIPns coordinate signaling with nuclear p53, AKT, and MDM2. Ultimately, we highlight that nuclear PIPns serve as a 'third messenger' within the p53-MDM2 axis, expanding the current framework of non-canonical nuclear signaling in cancer biology.
Insights
Nuclear phosphoinositides (PIPns) stabilize the tumor suppressor p53 by recruiting small heat shock proteins and activating AKT signaling. These PIPns act as a third messenger in the p53-MDM2 axis, impacting cancer biology.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Signaling
Background:
- The p53-MDM2 pathway is crucial for regulating cell growth and is frequently dysregulated in cancer.
- Nuclear phosphoinositides (PIPns) are increasingly recognized for their roles in intracellular signaling.
- Understanding novel regulatory mechanisms of the p53-MDM2 axis is vital for cancer therapy.
Purpose of the Study:
- To elucidate the molecular mechanisms by which nuclear PIPns modulate the p53-MDM2 interaction.
- To investigate the role of nuclear PIPns in stabilizing p53 and activating downstream signaling pathways.
- To establish nuclear PIPns as a key component of non-canonical nuclear signaling in cancer.
Main Methods:
- Dissection of molecular mechanisms involving nuclear PIPns, p53, MDM2, small heat shock proteins (sHSPs), and the PI3K-AKT pathway.
- Analysis of signaling coordination between nuclear p53, AKT, and MDM2.
- Exploration of PIPn-mediated regulation of protein-protein interactions within the nucleus.
Main Results:
- Nuclear PIPns stabilize p53 through the recruitment of sHSPs.
- Nuclear PIPns activate the nuclear phosphatidylinositol 3-kinase (PI3K)-AKT signaling cascade.
- Nuclear PIPns modulate MDM2 function, thereby regulating the p53-MDM2 interaction.
Conclusions:
- Nuclear PIPns function as a 'third messenger' within the p53-MDM2 axis.
- Nuclear PIPns expand the understanding of non-canonical nuclear signaling in cancer biology.
- Targeting nuclear PIPn-mediated signaling may offer novel therapeutic strategies for cancer.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Negative Regulator Molecules
PI3K/mTOR/AKT Signaling Pathway
DNA Damage can Stall the Cell Cycle

